Tuesday
SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
Location: Grand Ballroom West, 3rd Floor
Moderators:Ali F. AbuRahma, MD / Bruce A. Perler, MD, MBA / Thomas G. Brott, MD  
SESSION 10 SCHEDULE
7:50 AM - 7:55 AM A Data-Driven Look At Interventions For Carotid Disease: Do They Represent Exuberant Enthusiasm, Financial Opportunity For Industry, Doctors And Institutions, Or A Path To Excessive Risk
  Presenter(s):Colin P. Derdeyn, MD  
Location: Grand Ballroom West, 3rd Floor
CORONARY DISEASE IN CAROTID STENOSIS (CS) PATIENTS
7:56 AM - 8:01 AM Ten-Year Results Of A Multicenter RCT Showing The Long-Term Benefit In CS Patients Of Pre CEA Coronary Angiography And Treatment In Preventing Late MIs And Death
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
Location: Grand Ballroom West, 3rd Floor
8:02 AM - 8:07 AM Asymptomatic Coronary Artery Disease Is Deadly In Patients With Carotid Stenosis (CS) Whether The CS Is Treated Invasively Or Not: An RCT Shows How The Coronary Artery Disease Can Be Quantified And Treated To Reduce Myocardial Infarction And Improve Long-Term Survival
  Presenter(s):Dainis K. Krievins, MD / Christopher K. Zarins, MD  
Location: Grand Ballroom West, 3rd Floor
8:08 AM - 8:13 AM Practice Patterns (CAS, CEA, Medical Treatment, TCAR) For Treatment Of CS Are Changing Dramatically From Those In Previous RCTs: Evidence From A Population Based Analysis
  Presenter(s):Christian A. Behrendt, MD  
Location: Grand Ballroom West, 3rd Floor
VALUE OF CAROTID SCREENING
8:14 AM - 8:19 AM

Power Point Presentation with Synched Audio
The Case Against Screening For ACS (Like Lifeline): Who Profits: It May Lead To Unnecessary And Possibly Harmful Invasive Treatments
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
Location: Grand Ballroom West, 3rd Floor
8:20 AM - 8:25 AM Screening For ACS: Its Main Value Is In Guiding Lipid Treatment: How Low Should LDL-Cholesterol (LDL-C) Be Pushed And What Will It Do To Carotid Plaques
  Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS  
Location: Grand Ballroom West, 3rd Floor
8:26 AM - 8:32 AM Panel Discussion
DIFFERING VIEWS ON TREATMENT OF ACS AND REIMBURSEMENT POLICY
8:32 AM - 8:37 AM Plaque Progression In Asymptomatic Carotid Stenosis (ACS) Patients On Best Medical Therapy (BMT): Does It Mandate Invasive Therapy Or Continued BMT
  Presenter(s):Gianluca Faggioli, MD  
Location: Grand Ballroom West, 3rd Floor
8:38 AM - 8:43 AM

Power Point Presentation with Synched Audio
DEBATE: All ACS Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good And Should Not Have Been Widely Reimbursed By CMS
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
Location: Grand Ballroom West, 3rd Floor
8:44 AM - 8:49 AM DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated And Reimbursed Accordingly
  Presenter(s):Bruce A. Perler, MD, MBA  
Location: Grand Ballroom West, 3rd Floor
8:50 AM - 8:55 AM DEBATE: Both Views Are Wrong: Severe ACS Has Declined As A Cause Of Ischemic Stroke To <1% Per Year: So Only <5% Of ACS Patients Should Be Treated Invasively And Reimbursed Accordingly: Can Computer Analysis Of Plaque CT Imaging Help
  Presenter(s):Robert W. Chang, MD  
Location: Grand Ballroom West, 3rd Floor
8:56 AM - 9:01 AM CMS Expansion Of Reimbursement For CAS For Asymptomatic Disease: An Expensive And Potentially Harmful Decision: How Could CMS Disregard The Evidence, And Why Couldn't They Wait For CREST 2 Results
  Presenter(s):Joseph L. Mills, MD  
Location: Grand Ballroom West, 3rd Floor
9:02 AM - 9:07 AM Is Transfemoral CAS Being Overused One Year After CMS Increased Reimbursement For Treating Asymptomatic Carotid Stenosis
  Presenter(s):Sean P. Lyden, MD  
Location: Grand Ballroom West, 3rd Floor
9:08 AM - 9:14 AM Panel Discussion
9:15 AM - 9:30 AM Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 10
previous next